Charles Hay

Clinical Professor of Haemostasis and Thrombosis, Consultant Haematologist
University Department of Haematology, Manchester Royal Infirmary, Manchester, United Kingdom

Presentation(s):

• OC 27.4 - Recombinant factor VIII Fc showed better prophylactic effectiveness compared to standard half-life factor VIII in haemophilia A - results from A-SURE, a 24-month prospective, non-interventional study

  Sunday, July 10, 2022
  3:30 PM – 3:45 PM

• OC 63.4 - Little discrepancy of one-stage and chromogenic assays in a large international cohort of patients with non-severe hemophilia A and B (DYNAMO study)

  Tuesday, July 12, 2022
  3:30 PM – 3:45 PM